2024-09-27 - Analysis Report
## Johnson & Johnson (JNJ) Stock Analysis

**1. Performance Comparison:**

Johnson & Johnson (JNJ) is a multinational pharmaceutical, medical device, and consumer packaged goods company. 

**Cumulative Return:**

* JNJ: 34.19%
* S&P 500 (VOO): 133.29%

**Performance Gap:**

* JNJ is significantly lagging behind the S&P 500, with a cumulative return difference of -99.1%. Its relative performance is at the 5.56% percentile, meaning it has underperformed compared to the majority of its historical performance against the S&P 500.

**2. Recent Price Movement:**

* **Closing Price:** 160.6
* **5-day Moving Average:** 163.07
* **20-day Moving Average:** 165.11
* **60-day Moving Average:** 159.42

Currently, the stock price is below its 5-day, 20-day, and 60-day moving averages, suggesting a potential downtrend.

**3. Technical Indicators:**

* **RSI:** 35.45 - This indicates that JNJ is currently in the oversold territory, suggesting potential buying opportunities. 
* **PPO:** -0.53 - A negative value signifies a downtrend, which aligns with the recent price movement.
* **Delta_Previous_Relative_Divergence:** -4.81 - This indicates a recent short-term downtrend in the stock's relative performance.
* **Expected Return:** 0.0% - This suggests limited potential for upside growth in the next five years, based on the current market conditions.

**4. Recent Earnings and Outlook:**

| Date | EPS | Revenue |
|---|---|---|
| 2024-07-25 | 1.95 | 22.45 B$ |
| 2024-05-01 | 1.35 | 21.38 B$ |
| 2024-02-16 | 1.68 | 21.39 B$ |
| 2023-10-27 | 10.32 | 21.35 B$ |
| 2024-02-16 | 10.32 | 21.35 B$ |

The most recent earnings report (2024-07-25) showed EPS of 1.95, exceeding analyst expectations. This suggests a strong performance despite the current market conditions. However, it's important to note that JNJ is facing several challenges, including increased competition in the pharmaceutical industry, regulatory hurdles, and potential lawsuits related to its talcum powder products. 

**5. News and Recent Issues:**

* **Recent Market Outlook:**  The market outlook for JNJ remains cautious. Analysts are concerned about the potential impact of lawsuits and regulatory scrutiny on the company's long-term prospects.
* **Analyst Opinions:** While analysts remain optimistic about JNJ's long-term growth potential, they are generally hesitant to recommend buying the stock in the near term.
* **Performance Highlights:** JNJ's recent performance has been impacted by various factors, including the divestment of its consumer health business and increased competition in the pharmaceutical sector.

**6. Overall Analysis:**

Johnson & Johnson (JNJ) has underperformed the S&P 500 in recent years. The stock is currently showing signs of a downtrend, although its recent earnings results have been positive. Technical indicators suggest potential buying opportunities, but analysts are cautious due to the ongoing legal and regulatory challenges the company faces. While JNJ has a long history of stability and growth, its future prospects remain uncertain. Investors should closely monitor these developments before making any investment decisions.

**7. Report in English:**

This report provides a comprehensive analysis of Johnson & Johnson (JNJ) stock, covering its recent performance, technical indicators, earnings outlook, and market sentiment. 

**Key Takeaways:**

* JNJ has significantly underperformed the S&P 500, showcasing a substantial performance gap.
* Recent price movement suggests a potential downtrend, with the stock trading below its moving averages.
* Technical indicators reveal a mixed outlook, with oversold conditions and a negative PPO indicating a potential for both buying and selling opportunities.
* Despite recent positive earnings results, JNJ faces ongoing challenges, including lawsuits and regulatory scrutiny, which contribute to analyst caution.

Overall, JNJ remains a large, established company with a long history of success, but its future prospects are uncertain due to existing challenges. Investors should carefully consider these factors before making any investment decisions. 
